Co-founder and industry expert in structural biology and therapeutic discovery, Dr Hugh Morgan has led over 100 client projects from discovery through preclinical development. With a strong track record in antibody engineering, Hugh combines scientific precision with practical application to accelerate therapeutic innovation.

Mr Taylor Agnew

Taylor manages Antigenesis’ IT and infrastructure, ensuring seamless technical operations to support the team’s work in therapeutic development.

Dr Carles Blasi Brugué

Dr. Carles Blasi Brugué is a veterinary clinician with expertise in immunology and translational medicine. With a strong background in animal health and therapeutic development, he provides valuable clinical insights to Antigenesis, supporting the advancement of novel biologics for veterinary applications.